A $300M biotech merger gives Gyre a China drug business and new CEO - Stock Titan
HealthcareCaliforniaMerger
Gyre Therapeutics→Cullgen
May 4, 2026
Gyre Therapeutics — Acquisitions & M&A Deals
3 dealsTracking 3 M&A deals by Gyre Therapeutics.
Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company
HealthcareCaliforniaMerger
Gyre Therapeutics→Cullgen
May 4, 2026
GYRE THERAPEUTICS, INC. — SEC 8-K Filing
HealthcareCaliforniaMerger
Gyre Therapeutics→Cullgen
Mar 2, 2026